Valion Bio Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Valion Bio Inc's ROI in the second quarter of 2026?
Valion Bio Inc recorded a cumulative net loss of $-19 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -94.28%.

Within the Healthcare sector 615 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 4003, from total ROI ranking in the first quarter of 2026 at 4727.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	559.16 %	389.05 %	196.14 %	-3.09 %	-25.58 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	22	30	25	3	4
Return On Investment (TTM)	-94.28 %	-88.4 %	-101.56 %	-236.93 %	-209.76 %
VBIO's Overall Ranking	# 4003	# 4727	# 4388	# 4421	# 4451
Seq. Investment Change TTM	29.38 %	75.48 %	177.04 %	4.8 %	-4.01 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-19	-14	-9	-8	-6

VBIO Company Profile >> Back to VBIO Roi Comparisons >> See Annual VBIO Return On Investment

Return On Investment VBIO's Ranking
Within:	No.
Industry	# 144
Sector	# 616
Overall	# 4003

Return On Investment Statistics
High	Average	Low
55.77 %	-9374.81 %	-151524.63 %
(Sep 30 2024)		(Sep 30 2018)

Financial Statements
Valion Bio Inc's II. Quarter Investments	$ 22 Millions	VBIO's Balance sheet
Valion Bio Inc's II. Quarter Income	$ -7 Millions	Quarterly VBIO's Income Statement
VBIO's Income by Division		See VBIO's Income by Division

VBIO Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Mar 31 2021) 2021
Total Investments in Millions	25	3	4	4	1
Y / Y Investment Growth	885.01 %	-32.51 %	-6.03 %	362.94 %	-45.32 %
Net Income in Millions	-9	-6	0	-10	-1
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-35.55 %	-223.08 %	0 %	-252.59 %	-102.02 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VBIO's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VBIO's Competitors
Subscribers only: Roi for Valion Bio Inc's Suppliers
Subscribers only: Return On Investment for VBIO's Customers

Other Ratios
VBIO's Roa	VBIO's Inventory Turnover Ratio	VBIO's Growth Rates	VBIO's Dividend Statistics
	VBIO's Profitability Ratios	VBIO's Asset Turnover Ratio	VBIO's Dividend Growth
VBIO's Roe	VBIO's Valuation Ratios	VBIO's Financial Strength Ratios	VBIO's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:41:43+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.